{
    "title": "106_s2612",
    "content": "The Act may be cited as the \"Ecstasy Anti-Proliferation Act of 2000\". Congress finds that the illegal importation of MDMA (Ecstasy) has increased, with seizures rising significantly. Ecstasy use can cause long-lasting damage to the brain's serotonin system, affecting learning and memory. The popularity of Ecstasy has led to numerous websites providing information on its effects and production. Greater emphasis is needed on penalties, education on negative health effects, training for law enforcement, and reducing deaths related to Ecstasy. Targeting primarily college students, young professionals, and young people from middle- to high-income families. Reducing deaths caused by Ecstasy use and its combination with other drugs and alcohol through adequate funding for research by the National Institute on Drug Abuse. Research aims to identify vulnerable individuals, develop prevention approaches, understand toxic effects, reverse neurotoxic damage, develop treatments, and study the effects of Ecstasy. Research aims to better understand the effects of Ecstasy on children and adolescents, and translate findings into useful tools for dissemination. Enhanced punishment for ecstasy traffickers. The United States Sentencing Commission will amend Federal sentencing guidelines for offenses related to ecstasy and similar substances, in consultation with the Attorney General. The United States Sentencing Commission will amend Federal sentencing guidelines for offenses related to 3,4-methylenedioxy methamphetamine, including conspiracy to commit offenses under the Controlled Substances Act, the Controlled Substances Import and Export Act, or the Maritime Drug Law Enforcement Act. The Commission will increase penalties to be comparable to offenses involving any methamphetamine mixture and take necessary actions to enforce this subsection. The United States Sentencing Commission will amend Federal sentencing guidelines to reflect the need for aggressive law enforcement action and the dangers associated with offenses involving controlled substances, including the growing abuse and illegal importation of these substances. The Sentencing Commission will consider factors such as the young age of children using controlled substances and any other relevant factors when amending Federal sentencing guidelines for offenses involving controlled substances. Enhanced punishment for GHB traffickers is addressed in Section 4. The United States Sentencing Commission will amend the Federal sentencing guidelines for offenses related to GHB and gamma-butyrolactone trafficking under the Controlled Substances Act, with specific requirements outlined. The United States Sentencing Commission will review and amend the Federal Sentencing guidelines for offenses involving Schedule I and II depressants to increase penalties and deter these offenses. They will also ensure that offenses with significant quantities of these substances receive longer prison terms consistent with statutory maximum penalties. Additionally, the Commission will take any necessary actions to fulfill these requirements and consider the dangers associated with the use of these substances. The curr_chunk highlights the dangers of substance abuse, including overdose risks and illegal manufacturing of controlled substances. The United States Sentencing Commission is granted emergency authority to amend sentencing guidelines under the Act. Additionally, there is a prohibition on distributing information related to the manufacture or acquisition of controlled substances. Section 403 of the Controlled Substances Act prohibits the distribution of information related to the manufacture or acquisition of controlled substances. The Controlled Substances Act prohibits the distribution of information on manufacturing or acquiring controlled substances, with penalties including fines, imprisonment up to 10 years, or both. SEC. 7 mandates placing antidrug messages on federal government websites within 90 days. SEC. 8 expands prevention efforts for ecstasy abuse through grants. The Administrator has the authority to provide grants and agreements to public and nonprofit entities for school-based and community-based programs on the dangers of 3,4-methylenedioxy methamphetamine and related drugs. The funds must be used for effective and science-based initiatives. The funds provided can be used for planning, establishing, or administering prevention programs focused on 3,4-methylenedioxy methamphetamine or related drugs in high-risk districts and communities. This includes school-based programs targeting populations at risk of abuse and addiction, as well as community-based prevention programs for at-risk populations. The funds can be used for prevention activities related to 3,4-methylenedioxy methamphetamine or related drugs, including training law enforcement officials, health professionals, and parents on signs of abuse and addiction, as well as planning and evaluation of prevention efforts. The Administrator prioritizes grants for areas with high rates of abuse of 3,4-methylenedioxy methamphetamine or related drugs. Not less than $500,000 is allocated annually for effective prevention programs. The Administrator prioritizes grants for areas with high rates of abuse of 3,4-methylenedioxy methamphetamine or related drugs and allocates not less than $500,000 annually for effective prevention programs. An annual report containing analyses and evaluations is submitted to specific Senate and House committees. Authorization is given for appropriations of $5,000,000 for fiscal year 2001 and necessary sums for each succeeding fiscal year. The Director of the Office of National Drug Control Policy will ensure that the national media campaign addresses the reduction and prevention of abuse of 3,4-methylenedioxy methamphetamine or related drugs among young people in the United States."
}